Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Leiomyosarcoma Uterus × Doxorubicin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Large B-Cell, Diffuse 17 Sarcoma 15 Precursor Cell Lymphoblastic Leukemia-Lymphoma 9 Neoplasm Metastasis 8 Burkitt Lymphoma 8 Breast Neoplasms 8 Triple Negative Breast Neoplasms 7 Lymphoma, Follicular 7 Lymphoma, B-Cell 7 Lymphoma, T-Cell, Peripheral 6 Ovarian Neoplasms 5 Lymphoma 5 Hodgkin Disease 5 Osteosarcoma 4 Neoplasms 4 Lymphoma, Non-Hodgkin 4 Endometrial Neoplasms 4 Peritoneal Neoplasms 3 Neuroblastoma 3 Uterine Neoplasms 2 Stomach Neoplasms 2 Recurrence 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Plasmablastic Lymphoma 2 Lymphoma, Mantle-Cell 2 Liposarcoma 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia, Biphenotypic, Acute 2 Leukemia, B-Cell 2 Leiomyosarcoma 2

Interventions

Trabectedin 1 Doxorubicin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06524583 2025-03-30

L-UteCIN

UNICANCER

Phase 2 Recruiting

Leiomyosarcoma Uterus

Data powered by HemOnc (CC BY 4.0) Colophon ⚡